Chart 1
Seroprevalence of SARS-CoV-2 antibodies from infection by the number of days between self-reported infection and date of test completion among Canadians 18 years and older living in private dwellings, April to August 2022

>180 days 91-180 days 14-90 days <14 days 0 20 40 60 80 100 %
Source(s):
Canadian COVID-19 Antibody and Health Survey - Cycle 2 (5339).

Chart description


This is a bar clustered chart.

Seroprevalence of SARS-CoV-2 antibodies from infection by the number of days between self-reported infection and date of test completion among Canadians 18 years and older living in private dwellings, April to August 2022
  %
>180 days 68.0
91-180 days 86.3
14-90 days 89.9
&lt;14 days 55.0
Source(s):
Canadian COVID-19 Antibody and Health Survey - Cycle 2 (5339).
Date modified: